Related Experiment Video

Updated: Jul 15, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Decreased blood dendritic cell counts in type 1 diabetic children

Slavica Vuckovic1, Geoff Withers, Mark Harris

  • 1Mater Medical Research Institute, Aubigny Place, Raymond Tce, South Brisbane, QLD 4101, Australia. svuckovic@mmri.mater.org.au

Clinical Immunology (Orlando, Fla.)
|April 28, 2007
PubMed

Insights

Type 1 diabetes (T1D) patients show reduced numbers of blood dendritic cells (DCs), with counts normalizing in younger patients. DC responses to TLR-3 stimulation were similar to controls, suggesting a potential therapeutic target.

Area of Science:

  • Immunology
  • Endocrinology
  • Autoimmunity

Background:

  • Dendritic cells (DCs) play a crucial role in immune regulation and are implicated in autoimmune diseases.
  • Type 1 diabetes (T1D) is an autoimmune condition characterized by the destruction of pancreatic beta cells.
  • Previous research suggests potential alterations in immune cell populations in T1D, but DC specifics require further elucidation.

Purpose of the Study:

  • To investigate the numbers, phenotype, and functional responses of myeloid dendritic cells (MDCs) and plasmacytoid dendritic cells (PDCs) in new-onset (ND) and established (ED) T1D patients.
  • To compare DC characteristics in T1D patients with and without coeliac disease (CD).
  • To assess the impact of age and disease duration on DC populations in T1D.

Main Methods:

  • Quantification of absolute blood MDC and PDC numbers using flow cytometry.
  • Analysis of DC phenotype (HLA-DR, CD40, CD86 expression) and cytokine production (IL-12, IL-10, IL-6, TNF-alpha) following stimulation with poly I:C (a Toll-like receptor-3 ligand).
  • Comparison of DC parameters between T1D patients (ND and ED), controls, and patients with CD.

Main Results:

  • Absolute MDC and PDC numbers were significantly decreased in both ND and ED T1D patients compared to age-matched controls.
  • The reduction in DC counts was less pronounced in T1D patients with co-existing coeliac disease (CD) or CD alone.
  • Unlike controls, ND T1D children (2-10 years) did not exhibit an age-dependent decline in DC numbers, showing counts similar to older controls (15-17 years).
  • In ED patients, MDC and PDC numbers correlated with age at diagnosis but not disease duration.
  • No significant differences were observed in DC phenotype (HLA-DR, CD40, CD86) or cytokine production in response to poly I:C between T1D patients and controls.

Conclusions:

  • T1D is associated with a reduction in circulating blood DC numbers, particularly evident in patients without co-occurring CD.
  • The lack of age-related decline in DCs in young ND patients suggests a distinct immune developmental trajectory.
  • The functional capacity of DCs in T1D patients, as assessed by TLR-3 stimulation, appears preserved.
  • These findings suggest that low DC numbers may contribute to T1D pathogenesis, and interventions to increase DC levels could be a potential therapeutic strategy to protect beta cells.

More Related Videos

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes06:09

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes

Published on: June 22, 2016

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.